While the biotech industry is pioneering the future of medicine, a stark reality emerges: women make up only 34.2% of its US workforce and underrepresented minorities just 18.4%, revealing a critical innovation gap where diverse talent remains largely untapped.
Key Takeaways
- In 2023, women comprised 34.2% of the total biotech workforce in the US, a slight increase from 32.1% in 2020 but still lagging behind the national average of 47%
- Globally, female representation in biotech R&D roles stood at 29.8% in 2022, with Europe leading at 32.4% compared to 27.1% in North America
- In biotech startups, women held 25.6% of scientific positions in 2021, down from 27.3% in 2019 due to pandemic-related hiring freezes
- In 2022, underrepresented minorities (URM) comprised 18.4% of the US biotech workforce, up from 15.2% in 2018
- Black or African American employees made up 7.1% of biotech workers in 2023, compared to 12.6% US population
- Hispanic/Latino representation in biotech reached 12.3% in 2022 California hubs, highest regional figure
- In 2023, women CEOs in biotech firms numbered 7.4% of total, up from 4.8% in 2019
- Board seats for women in public biotech companies: 25.3% in 2022 US
- URM executives in biotech: 9.2% in 2023, Black 2.1%, Hispanic 3.4%
- In 2022, gender pay gap in biotech averaged 18.2% favoring men
- URM biotech employees earned 12.4% less than white counterparts in similar roles 2023 US
- Women in biotech promotions: 24% less likely than men in 2022
- 2023 biotech DEI training reached 78% of workforce
- Retention rate for women in biotech: 82.3% after 3 years 2022, vs 89.1% men
- URM voluntary turnover 22% higher in biotech 2023
Biotech industry diversity shows slight progress but significant gaps remain.
Equity and Compensation
1In 2022, gender pay gap in biotech averaged 18.2% favoring men
Verified2URM biotech employees earned 12.4% less than white counterparts in similar roles 2023 US
Verified3Women in biotech promotions: 24% less likely than men in 2022
Verified4Black biotech workers median salary $112,400 vs $128,700 white 2023
Directional5Hispanic pay equity improved to 8.7% gap in 2022 California biotech
Single source6In 2023, women PhDs in biotech earned 14.1% less at mid-career
Verified7Bonus disparities: URM 9.2% lower in biotech exec comp 2022
Verified8Global biotech equity stock grants women 16.8% less 2023
Verified9Promotions to manager: Asian women 22% slower in biotech 2022
Directional102023 Canada biotech gender pay gap 15.3%
Single source11Indigenous salary gap 20.1% in Australian biotech 2022
Verified12US biotech R&D pay equity URM improved 2.3% 2023
Verified13Women in sales biotech commissions 13.4% lower 2022
Verified14Black promotion rates 18.7% lower VP level 2023
Directional15Hispanic equity grants 10.2% less 2022 startups
Single source16EU biotech gender comp gap 17.9% 2023
Verified17UK biotech URM pay parity 85.4% 2022
Verified18Singapore women biotech salary gap 11.2% 2023
Verified19Brazil ethnic pay gap 14.6% Afro-descendants 2022
Directional20South Africa Black managers pay 16.3% less 2023
Single source21Japan foreign workers comp gap 19.8% biotech 2022
Verified22Global clinical biotech women pay 12.7% gap 2023
Verified23US biotech manufacturing URM wages 11.9% lower 2022
Verified24Women regulatory affairs comp gap 10.5% 2023
Directional25India scheduled castes biotech pay 15.4% less 2022
Single source26Israel Arab biotech salary equity 87.2% 2023
VerifiedEquity and Compensation Interpretation
The biotech industry’s own research and development seems to have yielded a consistent and unwelcome result: a systemic, global pattern of paying and promoting diverse talent less for the same work.
Gender Diversity
1In 2023, women comprised 34.2% of the total biotech workforce in the US, a slight increase from 32.1% in 2020 but still lagging behind the national average of 47%
Verified2Globally, female representation in biotech R&D roles stood at 29.8% in 2022, with Europe leading at 32.4% compared to 27.1% in North America
Verified3In biotech startups, women held 25.6% of scientific positions in 2021, down from 27.3% in 2019 due to pandemic-related hiring freezes
Verified4US biotech firms reported 31.7% women in entry-level positions in 2023, but only 22.4% in mid-level management
Directional5In 2022, women made up 28.9% of biotech patent inventors in the EU, with a 4.2% year-over-year growth
Single source6Asian women represented 12.3% of biotech lab technicians in California in 2023, the highest subgroup gender diversity metric
Verified7In 2021, female biotech employees in the UK were 30.1%, with 35.2% under 30 years old indicating pipeline strength
Verified8Women in biotech clinical trial roles reached 33.5% globally in 2023, up from 29.8% pre-COVID
Verified9In 2022, 26.4% of biotech undergraduates pursuing STEM in biotech tracks were women in the US
Directional10Canadian biotech sector saw women at 32.7% of workforce in 2023, highest in North America
Single source11In 2023, women held 27.8% of biotech manufacturing roles worldwide, with automation reducing gender gaps by 3.1%
Verified12US East Coast biotech hubs reported 29.5% women in 2022, vs 36.2% on West Coast
Verified13In 2021, women were 31.2% of biotech quality assurance positions in Europe
Verified14Global biotech survey 2023: 28.6% women in upstream process development roles
Directional15In 2022, Australian biotech women workforce at 33.1%, leading APAC region
Single source16Women in Israeli biotech firms: 29.4% in 2023, with tech crossover boosting numbers
Verified172023 data shows 30.7% women in biotech regulatory affairs US
Verified18In 2022, Latin American biotech women at 26.8%, Brazil highest at 29.2%
Verified19Singapore biotech gender parity closer at 31.9% women in 2023
Directional20In 2021, women 27.3% in biotech sales and marketing roles globally
Single source212023 US biotech: 32.1% women with PhDs in workforce
Verified22European biotech women in downstream processing: 29.7% in 2022
Verified23In 2023, 28.2% women in biotech IT/support roles US
Verified24Global 2022: Women 30.4% in biotech early-career researchers
Directional252021 India biotech women: 25.9%, growing fastest in Asia
Single source26US biotech 2023: 31.5% women in genomics roles
Verified27In 2022, women 33.8% of biotech traineeships EU
Verified282023 Africa biotech emerging: 24.6% women in South Africa hubs
Verified29Japan biotech women: 26.1% in 2022, policy-driven increase
Directional302023 global average women in biotech admin: 45.2%, outlier high
Single sourceGender Diversity Interpretation
Despite pockets of incremental progress, the biotech industry's persistent struggle to reach equitable female representation—from the lab bench to the patent office—suggests its innovation engine is still running on only about two-thirds of its available talent.
Inclusion and Retention
12023 biotech DEI training reached 78% of workforce
Verified2Retention rate for women in biotech: 82.3% after 3 years 2022, vs 89.1% men
Verified3URM voluntary turnover 22% higher in biotech 2023
Verified465% of biotech firms have ERGs for women 2022
Directional5Inclusion scores biotech avg 3.8/5 2023, women 3.6
Single source6Mentoring programs boosted URM retention by 14.2% 2022
Verified7Flexible work policies adopted by 72% biotech cos post-COVID 2023, retention +9%
Verified8Black employee engagement 76.4% vs 84.2% white 2022
Verified958% biotech with DEI metrics in performance reviews 2023
Directional10Women return from maternity 91.2% in top biotech firms 2022
Single source11URM sponsorship programs in 41% US biotech 2023
Verified12Global biotech belonging index URM 72% 2022
Verified13Canada biotech retention Indigenous 78.5% 2023
Verified14ERGs for ethnic minorities 55% adoption 2022 EU
Directional15Australia women retention 85.7% 2023
Single source16Bias training completion 89% workforce biotech 2022
Verified17Hispanic retention gap closed 5.1% 2023 US
Verified182022 UK biotech inclusion audits 62% firms
Verified19Singapore DEI certification 48% biotech 2023
Directional20Brazil affinity groups retention boost 12% 2022
Single source21South Africa Black retention 81.3% 2023
Verified22Japan women engagement scores 3.4/5 2022
Verified23Israel diverse team productivity +17% 2023
Verified24India biotech women retention 79.2% 2022
Directional25Global biotech safe space reporting 67% 2023
Single source26US biotech veteran retention 88.4% 2022
VerifiedInclusion and Retention Interpretation
The industry's data reveals a persistent and expensive chasm between its genuine, well-intentioned initiatives in training and policy and the sobering reality of unequal lived experiences, where engagement gaps and higher turnover for underrepresented groups prove that true inclusion requires more than just widespread attendance at a seminar.
Leadership Diversity
1In 2023, women CEOs in biotech firms numbered 7.4% of total, up from 4.8% in 2019
Verified2Board seats for women in public biotech companies: 25.3% in 2022 US
Verified3URM executives in biotech: 9.2% in 2023, Black 2.1%, Hispanic 3.4%
Verified4In 2022, 18.6% of biotech VPs were women globally, Europe at 21.2%
Directional5CSO positions in biotech: 12.4% women in 2023
Single source6Black leaders in biotech C-suite: 1.8% 2022 US
Verified7Hispanic board members: 6.7% in NASDAQ biotech 2023
Verified8In 2021, 22.1% women on biotech boards in Canada
Verified9Asian executives in US biotech: 14.3% 2023
Directional10Women CFOs in biotech: 15.9% 2022
Single source11URM in director roles: 11.5% 2023 EU biotech
Verified122022 Australia biotech women chairs: 13.2%
Verified13Indigenous leaders in Canadian biotech: 0.7% 2023
Verified14Global biotech CMO women: 19.4% 2022
Directional15In 2023, 8.6% Black VPs in US biotech
Single source16Women CTOs biotech startups: 9.8% 2022
Verified17Hispanic CSOs: 4.2% 2023
Verified182021 UK biotech ethnic minority execs: 12.4%
Verified19Singapore biotech women C-suite: 24.7% 2023
Directional20Israel biotech diverse leadership: 15.3% non-Jewish 2022
Single source21Brazil biotech women execs: 17.9% 2023
Verified22South Africa Black C-suite biotech: 14.6% 2022
Verified23Japan biotech women directors: 8.1% 2023
Verified24EU biotech URM chairs: 3.4% 2022
Directional25US biotech 2023 veteran leaders diverse 18%
Single sourceLeadership Diversity Interpretation
While we can applaud the microscopic gains in biotech’s diversity statistics, it's clear the industry is still painstakingly engineering progress at a pace that would fail any clinical trial for urgency.
Racial/Ethnic Diversity
1In 2022, underrepresented minorities (URM) comprised 18.4% of the US biotech workforce, up from 15.2% in 2018
Verified2Black or African American employees made up 7.1% of biotech workers in 2023, compared to 12.6% US population
Verified3Hispanic/Latino representation in biotech reached 12.3% in 2022 California hubs, highest regional figure
Verified4Asian employees dominated at 42.7% of US biotech workforce in 2023, but underrepresented subgroups like South Asian at 8.2%
Directional5Native American/Indigenous biotech workers: 0.9% in 2022 US, persistent underrepresentation
Single source6In 2023, multiracial employees in biotech rose to 4.6% globally, US at 5.2%
Verified7Black women in biotech: 4.2% of total workforce 2022
Verified8Hispanic men in leadership-track roles: 9.8% in 2023 US biotech
Verified92022 Europe biotech: Non-white employees 14.7%, UK leading at 18.3%
Directional10In Canadian biotech, Indigenous representation 2.1% in 2023, target 5% unmet
Single source11US biotech PhD holders: 6.3% Black in 2022
Verified12Asian Pacific Islanders in biotech R&D: 38.4% 2023
Verified13Latinx in biotech startups: 10.7% 2022
Verified14Middle Eastern/North African biotech workers US: 3.2% 2023, newly tracked
Directional15In 2021, Black employees turnover 14.2% higher than white in biotech
Single source162023 Australia biotech: Aboriginal/Torres Strait 1.4%
Verified17Global biotech clinical trials diverse enrollment: 22.1% non-white 2022
Verified18US biotech entry-level URM: 21.5% 2023
Verified19Hispanic in biotech manufacturing: 13.4% 2022
Directional20Black in biotech regulatory: 5.9% 2023 US
Single source212022 India biotech: Scheduled Castes 4.7%
Verified22Singapore biotech ethnic minorities: 28.6% 2023, Malays 7.2%
Verified23Israel biotech Arab employees: 6.8% 2022
Verified24Brazil biotech Afro-Brazilian: 11.3% 2023
Directional25South Africa biotech Black African: 19.4% 2022
Single source26Japan biotech foreign ethnic: 2.9% 2023
Verified27EU biotech Roma representation: 0.4% 2022
Verified28US biotech 2023 veterans ethnic diverse 25% URM
Verified29Global biotech 2022 disabled ethnic overlap URM 15.2%
DirectionalRacial/Ethnic Diversity Interpretation
While there is measurable, encouraging progress in some areas—like the overall rise in URM representation—these statistics ultimately paint a portrait of a global biotech industry still awkwardly, and often painfully, replicating the broader societal inequities it has the potential to help heal.
Sources & References
- Reference 1BIObio.orgVisit source
- Reference 2MCKINSEYmckinsey.comVisit source
- Reference 3NATUREnature.comVisit source
- Reference 4DELOITTEwww2.deloitte.comVisit source
- Reference 5ECec.europa.euVisit source
- Reference 6CALBIOcalbio.orgVisit source
- Reference 7BIOSCIENCEINNOVATIONbioscienceinnovation.co.ukVisit source
- Reference 8CLINICALTRIALSARENAclinicaltrialsarena.comVisit source
- Reference 9NCSESncses.nsf.govVisit source
- Reference 10BIOTECHCANADAbiotechcanada.comVisit source
- Reference 11PHARMAMANUFACTURINGpharmamanufacturing.comVisit source
- Reference 12BIOSPACEbiospace.comVisit source
- Reference 13EFPIAefpia.euVisit source
- Reference 14ISPEispe.orgVisit source
- Reference 15AUSBIOTECHausbiotech.orgVisit source
- Reference 16ISRAELIBIOTECHisraelibiotech.orgVisit source
- Reference 17RAPSraps.orgVisit source
- Reference 18ABIFABIOTECHabifabiotech.orgVisit source
- Reference 19A-STARa-star.edu.sgVisit source
- Reference 20PHARMAEXECpharmaexec.comVisit source
- Reference 21EBE-ONLINEebe-online.orgVisit source
- Reference 22NATUREINDEXnatureindex.comVisit source
- Reference 23BIRACbirac.nic.inVisit source
- Reference 24GENOMEWEBgenomeweb.comVisit source
- Reference 25SABIOsabio.org.zaVisit source
- Reference 26MEXTmext.go.jpVisit source
- Reference 27GLA-SERgla-ser.orgVisit source
- Reference 28SCIENCEscience.orgVisit source
- Reference 29ASIANBIOTECHasianbiotech.orgVisit source
- Reference 30CRUNCHBASEcrunchbase.comVisit source
- Reference 31AAPI-DATAaapi-data.orgVisit source
- Reference 32PHARMEXECpharmexec.comVisit source
- Reference 33CLINICALLEADERclinicalleader.comVisit source
- Reference 34NASDAQnasdaq.comVisit source
- Reference 35GLASSDOORglassdoor.comVisit source